ASCO 2019: Top Data and Developments

Research Objectives:

  • Capture areas of greatest excitement regarding data presented or developments that took place during the American Society of Clinical Oncology (ASCO) Annual Meeting, June 2019 in Chicago.

Method: MicroSurvey via InCrowd
Crowds: Oncologists and Hematology-Oncologists
Sample Size: n=80 physicians, each providing 3 separate mentions for a total of 240 unique data points
Fielding Period: 2 days immediately following conference close
Screening Criteria: Qualified respondents are US-based oncs and hem/oncs who: Attended the ASCO Annual Meeting held between May 31 – June 4, 2019 in Chicago, IL in person

One key finding:

  • ASCO 2019 attendees most commonly cited developments in Lung, Breast, and Prostate cancers as exciting developments at this year’s conference.

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more
RSV Tracker: Wave 3

RSV Tracker: Wave 3

Due to the surge in US respiratory syncytial virus (RSV) cases amongchildren and adults as reported in the news, InCrowd was interested inlearning more from Emergency Room physicians to understand thefollowing: • Growth in RSV cases over time• Severity-level changes...

read more